Biotechnology Focus Podcast

China’s 3SBio gains a North American through its $290 million purchase of Canada’s Therapure Biopharma Marck’s cladribine tablet Mavenclad achieves sustained control of relapsing multiple sclerosis. A patient enrolled in a CAR-T trial dies. I’m Nestor Arellano. And these are the stories we’ll discuss today on the Biotechnology Focus Podcast. But first, let’s talk about the future of Canada’s life science workplace and workforce +++++ What are the things that employees in Canada’s life science industry value about their workplace? What is it about their organization that keep life science professionals and workers engage and productive each day? How can you, as an employer attract and retain great talent? These are just some of the crucial questions many operators and owners of Canadian life science companies face as they work to grow their business. The key to finding the answers to these questions is data. And the best way to get that data is through the ongoing Biotechnology Focus, Stratford Managers Corpor